UnitedHealth [UNH] vs Centene [CNC] Detailed Stock Comparison
UnitedHealth
NYSE
Loading...
Centene
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: UnitedHealth wins in 11 metrics, Centene wins in 7 metrics, with 0 ties. UnitedHealth appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | UnitedHealth | Centene | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.69 | 6.35 | Centene |
| Price-to-Book Ratio | 2.58 | 0.47 | Centene |
| Debt-to-Equity Ratio | 75.58 | 63.91 | Centene |
| PEG Ratio | -0.66 | 3.72 | UnitedHealth |
| EV/EBITDA | 8.76 | 2.75 | Centene |
| Profit Margin (TTM) | 5.04% | 1.29% | UnitedHealth |
| Operating Margin (TTM) | 4.61% | -0.07% | UnitedHealth |
| EBITDA Margin (TTM) | 4.61% | N/A | N/A |
| Return on Equity | 21.65% | 7.44% | UnitedHealth |
| Return on Assets (TTM) | 6.46% | 2.50% | UnitedHealth |
| Free Cash Flow (TTM) | $20.71B | $-490.00M | UnitedHealth |
| Dividend Yield | 2.05% | N/A | N/A |
| 1-Year Return | -47.37% | -63.53% | UnitedHealth |
| Price-to-Sales Ratio (TTM) | 0.58 | 0.08 | Centene |
| Enterprise Value | $294.13B | $12.79B | UnitedHealth |
| EV/Revenue Ratio | 0.70 | 0.08 | Centene |
| Gross Profit Margin (TTM) | 17.93% | 6.05% | UnitedHealth |
| Revenue per Share (TTM) | $462 | $317 | UnitedHealth |
| Earnings per Share (Diluted) | $23.10 | $4.12 | UnitedHealth |
| Beta (Stock Volatility) | 0.44 | 0.40 | Centene |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
UnitedHealth vs Centene Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| UnitedHealth | 11.98% | 21.22% | 4.26% | 10.86% | -39.26% | -39.72% |
| Centene | 5.79% | 11.33% | -5.03% | -52.56% | -49.06% | -52.92% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| UnitedHealth | -47.37% | -44.56% | -3.22% | 161.45% | 861.75% | 494.00% |
| Centene | -63.53% | -70.60% | -54.39% | -12.31% | 461.93% | 290.81% |
Performance & Financial Health Analysis: UnitedHealth vs Centene
| Metric | UNH | CNC |
|---|---|---|
| Market Information | ||
| Market Cap | $244.53B | $12.85B |
| Market Cap Category | Mega cap | Large cap |
| 10 Day Avg. Volume | 16,995,752 | 16,243,891 |
| 90 Day Avg. Volume | 15,668,924 | 23,223,874 |
| Last Close | $304.01 | $28.49 |
| 52 Week Range | $234.60 - $630.73 | $25.08 - $80.59 |
| % from 52W High | -51.80% | -64.65% |
| All-Time High | $630.73 (Nov 11, 2024) | $98.53 (Aug 15, 2022) |
| % from All-Time High | -51.80% | -71.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.18% |
| Quarterly Earnings Growth | -0.19% | 0.22% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.01% |
| Operating Margin (TTM) | 0.05% | 0.00% |
| Return on Equity (TTM) | 0.22% | 0.07% |
| Debt to Equity (MRQ) | 75.58 | 63.91 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $104.67 | $55.80 |
| Cash per Share (MRQ) | $35.36 | $35.19 |
| Operating Cash Flow (TTM) | $28.96B | $1.73B |
| Levered Free Cash Flow (TTM) | $27.21B | $1.54B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.05% | N/A |
| Last 12-Month Dividend | $6.30 | N/A |
Valuation & Enterprise Metrics Analysis: UnitedHealth vs Centene
| Metric | UNH | CNC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.69 | 6.35 |
| Forward P/E | 9.03 | 3.72 |
| PEG Ratio | -0.66 | 3.72 |
| Price to Sales (TTM) | 0.58 | 0.08 |
| Price to Book (MRQ) | 2.58 | 0.47 |
| Market Capitalization | ||
| Market Capitalization | $244.53B | $12.85B |
| Enterprise Value | $294.13B | $12.79B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.70 | 0.08 |
| Enterprise to EBITDA | 8.76 | 2.75 |
| Risk & Other Metrics | ||
| Beta | 0.44 | 0.40 |
| Book Value per Share (MRQ) | $104.67 | $55.80 |
Financial Statements Comparison: UnitedHealth vs Centene
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UNH | CNC |
|---|---|---|
| Revenue/Sales | $111.62B | $46.62B |
| Cost of Goods Sold | $91.60B | $41.42B |
| Gross Profit | $20.01B | $5.20B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $5.15B | $1.53B |
| EBITDA | $6.23B | $1.85B |
| Pre-Tax Income | $4.08B | $1.75B |
| Income Tax | $510.00M | $432.00M |
| Net Income (Profit) | $3.57B | $1.31B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UNH | CNC |
|---|---|---|
| Cash & Equivalents | $30.72B | $14.82B |
| Total Current Assets | $96.29B | $41.29B |
| Total Current Liabilities | $113.47B | $37.14B |
| Long-Term Debt | $71.29B | $18.31B |
| Total Shareholders Equity | $105.17B | $28.02B |
| Retained Earnings | $97.93B | $16.66B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UNH | CNC |
|---|---|---|
| Operating Cash Flow | $2.45B | $937.00M |
| Capital Expenditures | $-898.00M | N/A |
| Free Cash Flow | $4.56B | $1.38B |
| Debt Repayment | $0 | $-958.00M |
| Common Stock Repurchase | $-3.00B | $-41.00M |
Short Interest & Institutional Ownership Analysis
| Metric | UNH | CNC |
|---|---|---|
| Shares Short | 15.23M | 27.78M |
| Short Ratio | 0.98 | 1.10 |
| Short % of Float | 0.02% | 0.06% |
| Average Daily Volume (10 Day) | 16,995,752 | 16,243,891 |
| Average Daily Volume (90 Day) | 15,668,924 | 23,223,874 |
| Shares Outstanding | 915.00M | 495.91M |
| Float Shares | 903.00M | 463.44M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.88% | 1.02% |
Dividend Analysis & Yield Comparison: UnitedHealth vs Centene
| Metric | UNH | CNC |
|---|---|---|
| Last 12-Month Dividend | $6.30 | N/A |
| Last 12-Month Dividend Yield | 2.05% | N/A |
| 3-Year Avg Annual Dividend | $6.33 | N/A |
| 3-Year Avg Dividend Yield | 0.38% | N/A |
| 3-Year Total Dividends | $18.99 | N/A |
| Ex-Dividend Date | Mar 10, 2025 | N/A |